New web app aims to give heart patients a voice in End-of-Life care
NCT ID NCT06090734
First seen Apr 29, 2026 · Last updated Jun 20, 2026 · Updated 9 times
Summary
This study tests a web-based platform called 'My Voice' that helps heart failure patients learn about their illness, decide on end-of-life care goals, and share those wishes with doctors and caregivers. About 244 patients in Singapore will use the tool to see if it increases advance care planning discussions. The goal is to make care planning easier and more patient-driven.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Duke-NUS
Singapore, Singapore, 169857, Singapore
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
My Voice web-based interactive platform
What this could lead to
If successful, this could provide a practical tool for heart failure patients to better communicate their end-of-life care wishes with doctors and family.
What could go wrong
This is an early-stage study with 244 participants, so results may not apply to all patients. The tool may not improve care discussions or reduce distress as hoped.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.